Evaluation of the efficacy of a new low-level laser therapy home protocol in the treatment of temporomandibular joint disorder-related pain: A randomized, double-blind, placebo-controlled clinical trial

被引:33
|
作者
Del Vecchio, Alessandro [1 ]
Floravanti, Miriam [1 ]
Boccassini, Armando [2 ]
Gaimari, Gianfranco [1 ]
Vestri, Annarita [3 ]
Di Paolo, Carlo [2 ]
Romeo, Umberto [1 ]
机构
[1] Univ Rome, Dept Oral & Maxillo Facial Sci Sapienza, COU Oral Pathol & Med, Via Caserta 6, I-00161 Rome, Italy
[2] Univ Rome, Dept TMJ Dysfunct, Dept Oral & Maxillo Facial Sci Sapienza, Rome, Italy
[3] Policlin Umberto I Rome, Dept Publ Hlth & Infect Dis, Rome, Italy
关键词
Temporomandibular disorders; laser therapy; photobiomodulation; pain management; laser; low-level laser therapy; MANAGEMENT; METAANALYSIS; DYSFUNCTION; MUSCLE;
D O I
10.1080/08869634.2019.1599174
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: This study analyzed a home, low-level laser therapy (LLLT) protocol to manage temporomandibular joint disorders (TMJDs)-related pain. Methods: Ninety TMJD patients (12M, 78F) between 18 and 73 years were randomly subdivided into three groups. Study group (SG) received 1-week home protocol LLLT by B-cure Dental Pro: 808 nm, 5 J/min, 250 mW, 15 KHz for 8', 40 J each, over pain area, twice daily. Placebo group (PG) followed the same protocol using sham devices. Drugs group (DG) received conventional drugs. Pain was evaluated by visual analog scale (VAS) before and after therapy. Results: Statistical analysis showed that treatment was effective (F(2,83) = 4.882; p = .010). Bonferroni post-hoc analysis indicated a lower pain decrease in PG. SG registered a 34-point decrease per patient, while in PG and DG, the reduction was 25.6 and 35.3, respectively. Conclusion: The study supports the efficacy of home LLLT management of TMJD related pain.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 50 条
  • [31] Lamotrigine Therapy for Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    Karin M. Belsito
    Paul A. Law
    Karen S. Kirk
    Rebecca J. Landa
    Andrew W. Zimmerman
    Journal of Autism and Developmental Disorders, 2001, 31 : 175 - 181
  • [32] Lamotrigine therapy for autistic disorder: A randomized, double-blind, placebo-controlled trial
    Belsito, KM
    Law, PA
    Kirk, KS
    Landa, RJ
    Zimmerman, AW
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2001, 31 (02) : 175 - 181
  • [33] Complementary low-level laser therapy for breast cancer-related lymphedema: a pilot, double-blind, randomized, placebo-controlled study
    Laurie Kilmartin
    Tara Denham
    Mei R. Fu
    Gary Yu
    Ting-Ting Kuo
    Deborah Axelrod
    Amber A. Guth
    Lasers in Medical Science, 2020, 35 : 95 - 105
  • [34] Complementary low-level laser therapy for breast cancer-related lymphedema: a pilot, double-blind, randomized, placebo-controlled study
    Kilmartin, Laurie
    Denham, Tara
    Fu, Mei R.
    Yu, Gary
    Kuo, Ting-Ting
    Axelrod, Deborah
    Guth, Amber A.
    LASERS IN MEDICAL SCIENCE, 2020, 35 (01) : 95 - 105
  • [35] Effectiveness of low-level laser therapy in temporomandibular joint disorders:: A placebo-controlled study
    Fikackova, H.
    Dostalova, T.
    Navratil, L.
    Klaschka, J.
    PHOTOMEDICINE AND LASER SURGERY, 2007, 25 (04) : 297 - 303
  • [36] The efficacy of low-level laser therapy for the treatment of myogenous temporomandibular joint disorder
    Ahrari, Farzaneh
    Madani, Azam S.
    Ghafouri, Zahra S.
    Tuner, Jan
    LASERS IN MEDICAL SCIENCE, 2014, 29 (02) : 551 - 557
  • [37] The efficacy of low-level laser therapy for the treatment of myogenous temporomandibular joint disorder
    Farzaneh Ahrari
    Azam S. Madani
    Zahra S. Ghafouri
    Jan Tunér
    Lasers in Medical Science, 2014, 29 : 551 - 557
  • [38] Escitalopram in the treatment of panic disorder: A randomized, double-blind, placebo-controlled trial
    Stahl, SM
    Gergel, I
    Li, DY
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (11) : 1322 - 1327
  • [39] Efficacy of individualized homeopathic treatment of insomnia: Double-blind, randomized, placebo-controlled clinical trial
    Michael, James
    Singh, Subhas
    Sadhukhan, Satarupa
    Nath, Arunava
    Kundu, Nivedita
    Magotra, Nitin
    Dutta, Susmit
    Parewa, Maneet
    Koley, Munmun
    Saha, Subhranil
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 43 : 53 - 59
  • [40] Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial
    Hoobehfekr, Saba
    Moghaddam, Hossein Sanjari
    Shalbafan, Mohammadreza
    Hashemi, Maryam Ghazizadeh
    Pirmoradi, Mohammad Mehdi
    Sakenian, Amirhossein
    Poopak, Amirhossein
    Kashefinejad, Shayan
    Yarahmadi, Masoomeh
    Akhondzadeh, Shahin
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 75 (02) : 57 - 62